NCT00830206View on ClinicalTrials.gov

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Healthy
Interventions
OTHER

Azithromycin

Oral Suspension

DRUG

Zithromax®

Oral Suspension

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00830206 - A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions | Biotech Hunter | Biotech Hunter